Active	Status	Sponsor type	Region	Phase	Filter
10 Active 4 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Quanbeck, Andrew R
NCT04011644: Mobile Health for Alcohol Use Disorders in Clinical Practice	Completed	N/A	558	US	A-CHESS self-monitored, A-CHESS peer-supported, A-CHESS clinically-integrated	University of Wisconsin, Madison, National Institute on Alcohol Abuse and Alcoholism (NIAAA)	Alcohol Drinking, Telemedicine	10/23	01/24
IMPACT-ALD, NCT06305624: Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease	Recruiting	N/A	298	US	Connections App	University of Wisconsin, Madison, National Institute on Alcohol Abuse and Alcoholism (NIAAA)	Alcohol Use Disorder, Alcohol-related Liver Disease	09/27	09/27
NCT06109571: Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders	Enrolling by invitation	N/A	806	US	Connections App	University of Wisconsin, Madison, National Institute on Drug Abuse (NIDA)	HIV Infections, Substance Use Disorders	03/27	03/27
Wang, Jennifer
NCT04963062: Moses vs. Thulium Laser Study	Completed	4	114	US	Holmium laser with Moses lasers, Holmium laser with thulium lasers	University of Wisconsin, Madison	Urinary Tract Stone	05/22	05/23
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)	Completed	3	1453	US	Placebo, Montelukast	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	07/23	01/24
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications	Completed	3	10956	US	Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	04/24	04/24
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)	Completed	3	3214	US	Placebo, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	06/24	11/24
BLAZE-1, NCT04427501: A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness	Completed	2/3	3307	US	LY3819253, LY-CoV555, Bamlanivimab, LY3832479, LY-CoV016, Etesevimab, LY3853113, bebtelovimab, Placebo	Eli Lilly and Company, AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd.	COVID-19	02/23	02/23
NCT06404086: RECOVER-SLEEP: Platform Protocol	Recruiting	2	1074	US	Modafinil, Modafinil Placebo, Solriamfetol, Solriamfetol Placebo, Melatonin, Melantonin Placebo, Tailored lighting (TL) Active, Tailored lighting (TL) Placebo	Duke University	Long COVID, Long COVID-19, Hypersomnia, Sleep Disturbance	07/25	07/25
NCT03959163: The Validity of the Quick Renal MRI in Pediatric Kidney Disease	Recruiting	N/A	100	US	Quick MRI	University of Wisconsin, Madison	Pyelonephritis, Pyelonephritis Acute, Renal Sclerosis	01/25	01/25
Rongstad, Kurt M
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Quanbeck, Andrew R
NCT04011644: Mobile Health for Alcohol Use Disorders in Clinical Practice	Completed	N/A	558	US	A-CHESS self-monitored, A-CHESS peer-supported, A-CHESS clinically-integrated	University of Wisconsin, Madison, National Institute on Alcohol Abuse and Alcoholism (NIAAA)	Alcohol Drinking, Telemedicine	10/23	01/24
IMPACT-ALD, NCT06305624: Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease	Recruiting	N/A	298	US	Connections App	University of Wisconsin, Madison, National Institute on Alcohol Abuse and Alcoholism (NIAAA)	Alcohol Use Disorder, Alcohol-related Liver Disease	09/27	09/27
NCT06109571: Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders	Enrolling by invitation	N/A	806	US	Connections App	University of Wisconsin, Madison, National Institute on Drug Abuse (NIDA)	HIV Infections, Substance Use Disorders	03/27	03/27
Wang, Jennifer
NCT04963062: Moses vs. Thulium Laser Study	Completed	4	114	US	Holmium laser with Moses lasers, Holmium laser with thulium lasers	University of Wisconsin, Madison	Urinary Tract Stone	05/22	05/23
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)	Completed	3	1453	US	Placebo, Montelukast	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	07/23	01/24
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications	Completed	3	10956	US	Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	04/24	04/24
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)	Completed	3	3214	US	Placebo, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	06/24	11/24
BLAZE-1, NCT04427501: A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness	Completed	2/3	3307	US	LY3819253, LY-CoV555, Bamlanivimab, LY3832479, LY-CoV016, Etesevimab, LY3853113, bebtelovimab, Placebo	Eli Lilly and Company, AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd.	COVID-19	02/23	02/23
NCT06404086: RECOVER-SLEEP: Platform Protocol	Recruiting	2	1074	US	Modafinil, Modafinil Placebo, Solriamfetol, Solriamfetol Placebo, Melatonin, Melantonin Placebo, Tailored lighting (TL) Active, Tailored lighting (TL) Placebo	Duke University	Long COVID, Long COVID-19, Hypersomnia, Sleep Disturbance	07/25	07/25
NCT03959163: The Validity of the Quick Renal MRI in Pediatric Kidney Disease	Recruiting	N/A	100	US	Quick MRI	University of Wisconsin, Madison	Pyelonephritis, Pyelonephritis Acute, Renal Sclerosis	01/25	01/25
Rongstad, Kurt M
No trials found